DNA Methylation–Based Prediction of Response to ICI in Metastatic Melanoma
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
DNA Methylation-Based Prediction of Response to Immune Checkpoint Inhibition in Metastatic Melanoma
J Immunother Cancer 2021 Jul 01;9(7)e002226, K Filipski, M Scherer, KN Zeiner, A Bucher, J Kleemann, P Jurmeister, TI Hartung, M Meissner, KH Plate, TR Fenton, J Walter, S Tierling, B Schilling, PS Zeiner, PN HarterFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.